Learn more about whether Alkermes plc or Alvotech is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Alvotech or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.

These appear as discolored, thickened, silver, or gray plaques that are hard to get rid of. You can have psoriasis anywhere ... linked with other allergic conditions (such as hay fever or asthma).

About 50% of the people who have plaque psoriasis experience a flare-up on the scalp at ... 2 “Para-phenylenediamine allergy: Current perspectives on diagnosis and management.” J Asthma Allergy.

Unlike plaque psoriasis which causes dry ... San Francisco School of Medicine and formerly practiced at Central Coast Allergy and Asthma in Salinas, California.

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press ...

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.